Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 TU. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iodine-promoted method for trifluoromethyl-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Patent CN114409714B discloses a Pd-catalyzed method for 1 3-disubstituted planar chiral metallocenes offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Novel one-pot method using metabisulfite and peroxides offers cost-effective, scalable production of key pharmaceutical intermediates with high purity.
Novel iodine-promoted synthesis of trifluoromethyl-triazoles offering cost-effective routes for pharmaceutical intermediates and agrochemicals.
Patent CN114409714A reveals a novel Pd-catalyzed method for synthesizing high-purity 1,3-disubstituted planar chiral metallocenes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN118908853A reveals a safe copper-catalyzed route for high-purity acrylonitrile intermediates, offering significant supply chain and cost advantages.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN105646382A reveals iodine-catalyzed triazole synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable high-purity output.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN115215783A details a novel copper-catalyzed synthesis of chiral propargyl-substituted oxindoles, offering high stereoselectivity and cost reduction in API manufacturing.
Patent CN113735756A details a novel Rh-catalyzed [4+1] cyclization for high-purity chiral isoindolinones, offering significant cost reduction in API manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Patent CN110467556B reveals a mild Ni(II) catalytic route for 3-substituted isoindolinones, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel AgNO3 catalyzed method ensures high purity and yield. Offers significant supply chain stability and cost efficiency for global pharmaceutical intermediates manufacturing partners.
Patent CN112239456A reveals a novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Novel iodine-promoted metal-free route for high-purity triazole intermediates. Reduces cost and simplifies supply chain for global pharma manufacturing.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable production for global API manufacturers.